Myocardial inflammation on cardiovascular magnetic resonance predicts left ventricular function recovery in children with recent dilated cardiomyopathy

European Heart Journal Cardiovascular Imaging

Volumn 16, Issue 7, 2015, Pages 756-762

  Raimondi, Francesca ^a   Iserin, Franck ^a   Raisky, Olivier ^a   Laux, Daniela ^a   Bajolle, Fanny ^a   Boudjemline, Younes ^a   Boddaert, Nathalie ^a   Bonnet, Damien ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cardiac magnetic resonance imaging; Children; Heart failure; Inflammatory cardiomyopathy; Myocarditis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; IMMUNOGLOBULIN; INOTROPIC AGENT; SPIRONOLACTONE; TROPONIN; WARFARIN; GADOLINIUM PENTETATE;

ADOLESCENT; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIURETIC THERAPY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART VENTRICLE FUNCTION; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; NEWBORN; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SURVIVAL; CARDIOMYOPATHY, DILATED; COHORT ANALYSIS; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; IMAGE ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADOLESCENT; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDITIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84942084937     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jev002     Document Type: Article

References (34)

1. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB et al. European Society of CardiologyWorking Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636-48, 2648a-2648d.
2. Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC et al. National Australian Childhood Cardiomyopathy Study. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348:1639-46.
3. Levine MC, Klugman D,Teach SJ. Update on myocarditis in children. Curr Opin Pediatr 2010;22:278-83.
4. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S et al. Incidences, causes and outcomes of dilated cardiomyopathy in children. JAMA 2011;296: 1867-76.
5. Noren GR, Staley NA, Bandt CM, Kaplan EL. Occurrence of myocarditis in sudden death in children. J Forensic Sci 1977;22:188-96.
6. Dancea AB. Myocarditis in infants and children: a review for the paediatrician. Paediatr Child Health 2001;6:543-5.
7. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999;99:1091-100.
8. Alexander PM, Daubeney PE, NugentAW, Lee KJ, Turner C, ColanSDet al. National Australian Childhood Cardiomyopathy Study. Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy. Circulation 2013;128:2039-46.
9. DecGW, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DCS et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies-clinical features, histologic correlates and clinical outcome. N Engl J Med 1985;312:885-90.
10. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. J Am Coll Cardiol 2007;50: 1914-31.
11. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006;113: 593-5.
12. Jeserich M, Konstantinides S, Pavlik G, Bode C, Geibel A. Non-invasive imaging in the diagnosis of acute viral myocarditis. Clin Res Cardiol 2009;98:753-63.
13. Wagner A, Schulz-Menger J, Dietz R, Friedrich MG. Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. MAGMA 2003;16:17-20.
14. McCrohon JA, Moon JCC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJS et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.
15. De Cobelli F, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. JAmColl Cardiol 2006;47: 1649-54.
16. Mahrholdt H,Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006;114:1581-90.
17. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009;53:1475-87.
18. Mavrogeni S, Bratis K, Karanasios E, Georgakopoulos D, Kaklis S, Varlamis G et al. Evaluation of myocarditis in a pediatric population using cardiovascular magnetic resonance and endomyocardial biopsy. Int J Cardiol 2012;160:192-5.
19. Vermes E, Childs H, Faris P, Friedrich MG. Predictive value of CMR criteria for LV functional improvement in patients with acute myocarditis. Eur Heart Cardiovasc Imaging 2014;15:1140-4.
20. Mahrholdt H, Goedecke C,Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8.
21. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-9.
22. Zagrosek A, Abdel-Aty H, Boyé P,Wassmuth R, Messroghli D, UtzWet al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2009;2:131-8.
23. Abdel-Aty H, Boyé P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005;45:1815-22.
24. Gagliardi MG, Bevilacqua M, Di Renzi P, Picardo S, Passariello R, Marcelletti C. Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol 1991;68: 1089-91.
25. Mavrogeni S, Bratis K, Karanasios E, Georgakopoulos D, Kaklis S, Varlamis G et al. CMR evaluation of cardiac involvement during the convalescence of Kawasaki disease. JACC Cardiovasc Imaging 2011;4:1140-1.
26. Foerster SR, Canter CE, Cinar A, Sleeper LA,Webber SA, Pahl E et al. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail 2010;3:689-97.
27. Amabile N, Fraisse A, Bouvenot J, Chetaille P, Ovaert C. Outcome of acute fulminant myocarditis in children. Heart 2006;92:1269-73.
28. Kleinert S, Weintraub RG, Wilkinson JL, Chow CW. Myocarditis in children with dilated cardiomyopathy: incidence and outcomeafter dual therapy immunosuppression. J Heart Lung Transplant 1997;16:1248-54.
29. Lee KJ, McCrindle BW, Bohn DJ, Wilson GJ, Taylor GP, Freedom RM et al. Clinical outcomes of acute myocarditis in childhood. Heart 1999;82:226-33.
30. Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE. Dilated cardiomyopathy in children: determinants of outcome. Br Heart J 1994;72:246-50.
31. Akagi T, Benson LN, Lightfoot NE, Chin K, Wilson G, Freedom RM. Natural history of dilated cardiomyopathy in children. Am Heart J 1991;121:1502-6.
32. Moon J,Ko YG, Chung N, HaJW, Kang SM, Choi EYet al. Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy. Can J Cardiol 2009;25:e147-50.
33. Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 1998;101:369-76.
34. Vashist S, Singh GK. Acute myocarditis in children: current concepts and management. Current Treat Options Cardiovasc Med 2009;11:383-91.